Rockwell Medical (RMTI) EBITDA (2010 - 2026)
Rockwell Medical (RMTI) posted EBITDA of -$1.5 million for Q1 2026, down 271.86% on a QoQ basis from -$398000.0 in Q4 2025, and down 8.82% year-over-year from -$1.6 million in Q1 2025.
Rockwell Medical (RMTI) EBITDA (2010 - 2026) Analysis & Trends
Rockwell Medical's EBITDA history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- Quarterly EBITDA fell 8.82% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (down 941.08% YoY) and the FY2025 annual result came in at -$4.7 million, down 871.55% from the prior year.
- EBITDA was -$1.5 million for Q1 2026 at Rockwell Medical, down from -$398000.0 in the prior quarter.
- Across five years, EBITDA topped out at $1.9 million in Q3 2024 and bottomed at -$6.6 million in Q1 2022.
- A 5-year average of -$1.7 million and a median of -$1.4 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2024 — EBITDA jumped 211.46% — and 2025, when it slumped 361.94%.
- Rockwell Medical's EBITDA stood at -$2.0 million in 2022, then surged by 72.18% to -$547000.0 in 2023, then rose by 5.12% to -$519000.0 in 2024, then climbed by 23.31% to -$398000.0 in 2025, then sank by 271.86% to -$1.5 million in 2026.
- Business Quant data shows RMTI's EBITDA at -$1.5 million in Q1 2026, -$398000.0 in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.48 Mn |
| Dec 31, 2025 | -398,000.00 |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.35 Mn |
| Mar 31, 2025 | -1.36 Mn |
| Dec 31, 2024 | -519,000.00 |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 515,000.00 |
| Mar 31, 2024 | -1.32 Mn |
| Dec 31, 2023 | -547,000.00 |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -2.96 Mn |
| Mar 31, 2023 | -1.43 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | -3.71 Mn |
| Jun 30, 2022 | -4.48 Mn |
| Mar 31, 2022 | -6.63 Mn |
| Dec 31, 2021 | -8.36 Mn |
| Sep 30, 2021 | -6.97 Mn |
| Jun 30, 2021 | -7.82 Mn |